Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julio C Chavez
University Health Network Princess Margaret Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Kansas Clinical Research Center
Fairway, Kansas, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Sept 2016
- Primary completion
- 18 Dec 2024
- Completion
- 24 Dec 2026
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 21
- Registry id
- NCT02520791
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.